Literature DB >> 22473098

Breast cancer: Risk and mortality after oestrogen-alone therapy--is it safe?

Leslie Bernstein.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22473098     DOI： 10.1038/nrclinonc.2012.62

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

Authors:  Garnet L Anderson; Rowan T Chlebowski; Aaron K Aragaki; Lewis H Kuller; JoAnn E Manson; Margery Gass; Elizabeth Bluhm; Stephanie Connelly; F Allan Hubbell; Dorothy Lane; Lisa Martin; Judith Ockene; Thomas Rohan; Robert Schenken; Jean Wactawski-Wende
Journal:  Lancet Oncol       Date:  2012-03-07       Impact factor: 41.316

Review 2.  Update in hormone therapy use in menopause.

Authors:  Hugh S Taylor; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2011-02       Impact factor: 5.958

3.  Unopposed estrogen therapy and the risk of invasive breast cancer.

Authors:  Wendy Y Chen; JoAnn E Manson; Susan E Hankinson; Bernard Rosner; Michelle D Holmes; Walter C Willett; Graham A Colditz
Journal:  Arch Intern Med       Date:  2006-05-08

4.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

5.  Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.

Authors:  Andrea Z LaCroix; Rowan T Chlebowski; JoAnn E Manson; Aaron K Aragaki; Karen C Johnson; Lisa Martin; Karen L Margolis; Marcia L Stefanick; Robert Brzyski; J David Curb; Barbara V Howard; Cora E Lewis; Jean Wactawski-Wende
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

6.  Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.

Authors:  David J Press; Jane Sullivan-Halley; Giske Ursin; Dennis Deapen; Jill A McDonald; Brian L Strom; Sandra A Norman; Michael S Simon; Polly A Marchbanks; Suzanne G Folger; Jonathan M Liff; Ronald T Burkman; Kathleen E Malone; Linda K Weiss; Robert Spirtas; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2010-11-25       Impact factor: 4.897

7.  Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.

Authors:  Gillian K Reeves; Valerie Beral; Jane Green; Toral Gathani; Diana Bull
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

8.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

9.  Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis.

Authors:  K K Steinberg; S J Smith; S B Thacker; D F Stroup
Journal:  Epidemiology       Date:  1994-07       Impact factor: 4.822

10.  Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

Authors:  Gerardo Heiss; Robert Wallace; Garnet L Anderson; Aaron Aragaki; Shirley A A Beresford; Robert Brzyski; Rowan T Chlebowski; Margery Gass; Andrea LaCroix; JoAnn E Manson; Ross L Prentice; Jacques Rossouw; Marcia L Stefanick
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.